CD34+-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a large cohort study focusing on haploidentical transplantation.
Poor graft function (PGF) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). CD34+-selected stem cell boost has shown promise; however, data in the haploidentical setting and after failure of thrombopoietin receptor agonists (TPO-RAs) are limited. Patients who recei...